⌘K
t
On April 4, 2023, Cellular Goods PLC announced the grant of options and warrants to two directors. CFO Bruna Nikolla was granted options over 7,000,000 ordinary shares at an exercise price of 1.2 pence (transaction date March 28, 2023). Non-Executive Director Gill Whitty-Collins received a warrant over 2,000,000 ordinary shares at an exercise price of 2.9 pence (transaction date April 3, 2023); for both, one third vests on the first anniversary of their engagement, with the remaining shares vesting in 24 equal monthly instalments thereafter.
| Date | 4 Apr 2023 |
| Time | 17:12:37 |
| Category | Director/PDMR dealings |
| ID | 3744V |
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Press release
4 April 2023
Cellular Goods PLC
("Cellular Goods" or "the Company")
Grant of Options and Warrants
Cellular Goods (LSE: CBX) a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, announces that it has granted certain options and warrants in accordance with the terms agreed with each of Bruna Nikolla, the Company's Chief Financial Officer, and Gill Whitty-Collins, a non-executive director of the Company, in connection with their respective appointments.
Bruna Nikolla has been granted options over 7,000,000 ordinary shares of £0.001 each in the Company ("Ordinary Shares") at an exercise price of 1.2 pence per Ordinary Share. Gill Whitty Collins has been granted a warrant over 2,000,000 Ordinary Shares at an exercise price of 2.9 pence per Ordinary Share. The exercise prices reflect the prevailing share price at the date of their respective engagements with the Company. One third of the options and warrants (respectively) vest on the first anniversary of their respective engagement with the Company, with the remaining shares vesting in 24 equal monthly instalments thereafter.
For further information please contact:
|
Cellular Goods |
|
|
Darcy Taylor Chairman and interim CEO Neil Thapar Investor Relations |
Via Tancredi +44 207 887 7633
+44 787 645 5323 |
|
Tennyson Securities |
|
|
Corporate Broker & Adviser Peter Krens Alan Howard |
+44 207 186 9030 |
|
Novum Securities |
|
|
Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
|
Tancredi Intelligent Communication |
|
|
Media Relations Helen Humphrey Charlie Hobbs cellulargoods@tancredigroup.com |
+44 744 922 6720 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD wellness with the first products launched in December 2021. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
The following information relating to the transaction by a Director has been filed with the Financial Conduct Authority in accordance with Article 19(1) of UK MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Bruna Nikolla |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Director |
||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Cellular Goods PLC |
||||
|
b) |
LEI |
213800IXPX4Z2MKX2U28 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of £0.001 each
ISIN: GB00BK964W87 |
||||
|
b) |
Nature of the transaction |
Grant of options over 7,000,000 ordinary shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A single transaction |
||||
|
e) |
Date of the transaction |
28 March 2023 |
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Gill Whitty-Collins |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Director |
||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Cellular Goods PLC |
||||
|
b) |
LEI |
213800IXPX4Z2MKX2U28 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of £0.001 each
ISIN: GB00BK964W87 |
||||
|
b) |
Nature of the transaction |
Grant of warrant over 2,000,000 ordinary shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A single transaction |
||||
|
e) |
Date of the transaction |
3, April 2023 |
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||